Hisun Biomaterials (688203.SH) released its first three quarters performance, with net profit attributable to parent of 27.45 million yuan, a year-on-year increase of 459.49%.

Zhitong Finance APP News, Hisun Biomaterials (688203.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 953 million yuan, a year-on-year increase of 53.41%; net profit attributable to the parent company was 27.45 million yuan, a year-on-year increase of 459.49%; net profit after deducting non-recurring gains and losses was 26.85 million yuan, a year-on-year increase of 623.95%; basic earnings per share was 0.14 yuan.